Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Clinical trial NCT00310128 · WITHDRAWN

Trial details

NCT number: NCT00310128
Sponsor: AIDS Malignancy Consortium
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

AIDS-related Lymphoma Adult Non-Hodgkin's Lymphoma Anaplastic Large Cell Lymphoma

Start date: 2006-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.